Neuronetics Inc (STIM)
0.75
-0.03
(-3.85%)
USD |
NASDAQ |
Sep 27, 16:00
0.7875
+0.04
(+5.00%)
After-Hours: 20:00
Neuronetics SG&A Expense (TTM): 72.52M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 72.52M |
March 31, 2024 | 71.83M |
December 31, 2023 | 72.74M |
September 30, 2023 | 73.15M |
June 30, 2023 | 72.70M |
March 31, 2023 | 74.98M |
December 31, 2022 | 75.50M |
September 30, 2022 | 73.75M |
June 30, 2022 | 71.98M |
March 31, 2022 | 67.66M |
December 31, 2021 | 63.30M |
September 30, 2021 | 59.01M |
June 30, 2021 | 53.02M |
March 31, 2021 | 49.45M |
Date | Value |
---|---|
December 31, 2020 | 50.80M |
September 30, 2020 | 54.26M |
June 30, 2020 | 58.65M |
March 31, 2020 | 62.27M |
December 31, 2019 | 60.45M |
September 30, 2019 | 59.98M |
June 30, 2019 | 58.25M |
March 31, 2019 | 55.38M |
December 31, 2018 | 51.93M |
September 30, 2018 | 48.03M |
June 30, 2018 | 43.94M |
March 31, 2018 | 39.27M |
December 31, 2017 | 36.47M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
49.45M
Minimum
Mar 2021
75.50M
Maximum
Dec 2022
64.90M
Average
65.48M
Median
SG&A Expense (TTM) Benchmarks
Quest Diagnostics Inc | 1.643B |
Delcath Systems Inc | 28.74M |
Star Equity Holdings Inc | 16.08M |
CytoSorbents Corp | 37.41M |
Progyny Inc | 179.01M |